Back to search
FDAFDA · Food and drugs·Recall number D-0242-2018

SPIRIVA HandiHaler (tiotropium bromide inhalation powder) 18 mcg/capsule (90 capsules (unit dose blisters) per box, Rx Only, Made in Germany, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877, NDC 0597-0075-47

Published February 7, 2018 · Recall initiated: December 14, 2017

Summary

FDA records drug Class II recall D-0242-2018, published February 7, 2018 and initiated December 14, 2017. Recalling firm: Boehringer Ingelheim Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 45,008 units/90 capsules each unit; Lot: Lot # 606478; Exp. 03/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if SPIRIVA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SPIRIVA
Manufacturer
Boehringer Ingelheim Pharmaceuticals, Inc.
Distributor
Distributed nationwide
Lot
Lot # 606478; Exp. 03/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was SPIRIVA HandiHaler (tiotropium bromide inhalation powder) 18 mcg/capsule (90 capsules (unit dose blisters) per box, Rx Only, Made in Germany, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877, NDC 0597-0075-47 recalled?

Yes. FDA published recall D-0242-2018 on February 7, 2018. Reported hazard: Failed Stability Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SPIRIVA.